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Human platelet alloantigens (HPA) are important in neonatal
alloimmune thrombocytopenia (NAIT), posttransfusion purpura
(PTP), platelet transfusion refractoriness, passive alloimmune
thrombocytopenia, and transplantation-associated alloimmune
thrombocytopenia. Thus, HPA genotyping is essential in diagnosis
and treatment. We analyzed HPA-1 to 6 and Gov alleles, using PCR
with sequence specific primers (PCR-SSP) in 500 Thai blood donors
who had been HLA class I antigen typed. HPA-4a was present in all
samples. HPA-1b, -2b, -5b, and -6b were rare, and HPA-4b was not
found. HPA-3a and -3b showed frequencies of 56.0 percent and
44.0 percent, respectively. Gova and Govb showed frequencies of
49.1 percent and 50.9 percent, respectively. The prevalence rates
of HPA-1 to 6 gene frequencies (GFs) were consistent with those of
other Asian populations rather than those of Caucasians. We also
report on the GFs of Gova and Govb, which also are comparable to
those of Asian populations. Our results could establish a useful
HPA- and HLA-matched plateletpheresis donor file and provide an
improvement of platelet alloantibody detection in alloimmune
thrombocytopenic patients, and, therefore, a more effective platelet
transfusion program. Immunohematology 2005;21:5–9.
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Human platelet alloantigens (HPA) become
clinically relevant if the antibody causes enhanced
platelet destruction,resulting in thrombocytopenia and
hemorrhagic diathesis. Five clinical entities due to
platelet-specific alloantibodies can be distinguished:
neonatal alloimmune thrombocytopenia (NAIT), post-
transfusion purpura (PTP), platelet transfusion
refractoriness, passive alloimmune thrombocytopenia,
and transplantation-associated alloimmune thrombo-
cytopenia.1 Platelet transfusion refractoriness,which is
defined as a low CCI after platelet transfusion, is a
common problem in multitransfused patients.
Immunologic refractoriness to platelet transfusion is
caused by alloantibodies reacting with transfused
antigens such as ABO, HLA class I, and HPA antigens.
Although HLA alloimmunization is the most common,
HPA antibodies are also clinically significant.1–4
In Thailand, platelet antigen typing of blood donors
is not routinely performed, except for population
genetic studies.5–7 Usually, ABO matched and negative
platelet crossmatched units are transfused to
multitransfused patients with platelet refractoriness.
The National Blood Centre, Thai Red Cross Society,
has performed platelet antibody screening and
identification in 163 thrombocytopenic patients, using
the solid phase red cell adherence assay,since 1993. HLA
and HPA antibodies were detected in 49.63 percent and
6.13 percent of patients, respectively. In addition, 40.0
percent of HPA antibodies could not be identified due to
the limited availability of HPA-genotyped panels.8
Having a panel of HLA- and HPA-typed donors would 
be helpful.4 Different PCR techniques have been
introduced, such as PCR with RFLP and PCR with
sequence specific primers (PCR-SSP). The PCR-SSP
technique has been shown to be a simpler and more
reliable method for several HPA genotypes.9–14
This study analyzed HPA-1 to 6 and Gov alleles,
using PCR-SSP in Thai blood donors who had been HLA
class I antigen typed to establish HPA-genotyped panels
for identification of HPA antibodies in routine testing.
Materials and Methods
Subjects
Five hundred healthy Thai blood donors at the
National Blood Centre,Thai Red Cross Society,who had
been HLA class I antigen typed, were included in this
study. The study comprised 369 males and 131 females,
with ages ranging from 19 to 58 years. The mean age
was 36 years. EDTA blood (3 mL) was collected from
each donor and informed consent was obtained from
all subjects.
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DNA standards
Known HPA-1 to 6 and Gov DNA samples,
provided by the Australian Platelet Antibody
Workshop in association with the Australian and
New Zealand Society of Blood Transfusion and
Central Blood Centre, Japanese Red Cross Society,
were used as a standard in the PCR-SSP method.
HPA genotyping
Genomic DNA was extracted from whole blood
by the salting-out technique (Pel-Freez,Brown Deer,
WI). The PCR-SSP for HPA-1 to 6 and Gov systems
was performed as previously described,9,15,16 with
some modification. To increase specificity for
detection of HPA-3b, two bases were extended at
the 5´ end of the primer. The primers used in this
study are listed in Table 1. Briefly, the PCR reactions
were carried out in 10 µL aliquots containing
50–100 ng of genomic DNA and PCR buffer (67 mM
Tris HCL pH 8.8, 16 mM ammonium sulfate, 0.01%
Tween 20,0.5 µM each of dNTP and 1.5 mM MgCl2).
Each PCR reaction contained 0.1 to 0.4 µM of the
control primers, 0.1 to 0.5 µM of the allele-specific
primers, and 0.75 units of AmpliTaq DNA
polymerase (Applied Biosystems, Foster City, CA).
PCR amplifications were carried out in a GeneAmp
PCR System 2700 (Applied Biosystems) or in a PTC-
200 (MJ Research,Waltham, MA). The PCR program
consisted of one cycle: 96°C for 1 minute; five
cycles: 96°C for 25 seconds, 68°C for 45 seconds, 72°C
for 30 seconds; 28 cycles: 96°C for 25 seconds, 61°C for
45 seconds,72°C for 30 seconds;and one cycle:72°C for
3 minutes. The amplified products were
electrophoresed through 2.0% agarose gel containing
0.5 µg/mL ethidium bromide. The gel was run at 100 V
for 30 minutes in 0.5X TBE and visualized under UV
transilluminator. The reaction was photographed and
the HPA alleles were assessed.
Reproducibility of SSP typing
Ten samples were randomly repeated for HPA-1 to
6 and Gov SSP-typing, to test for reproducibility.
Statistical analysis
Genotype and gene frequencies (GF) were
determined by direct counting. The validity of the
Hardy-Weinberg equilibrium was tested by calculating
expected numbers of subjects for each genotype using
2 × af[a] × af[b] × N for heterozygotes and af[a or b]2
× N for homozygotes, where af[a] and af[b] are the
allele frequencies of the HPA-1 to 6 and Gov a and b
alleles, respectively, and N is the number of subjects
typed. The differences in HPA genotype distribution
between the two groups were tested for significance
by chi-square and by Fisher’s exact test.
Results
In this study, the simultaneous determination of
HPA-1 to 6 and Gov genotyping by PCR-SSP resulted in
PCR products of the following sizes: 90 bp for HPA-1,
258 bp for HPA-2, 267 and 269 bp for HPA-3a and -3b,
120 bp for HPA-4, 246 bp for HPA-5, 238 and 239 bp for
HPA-6a and -6b, and 225 bp for Gov, respectively. In all
reactions, the human growth hormone (HGH) internal
control gave an expected band of 429 bp. Additional
smaller, nonspecific products were seen in HPA-3b and
-6b, while a larger nonspecific product was also seen in
HPA-4b, as previously reported,4 but these did not
interfere with the interpretation of the HPA genotypes
(Fig. 1).
The genotype and gene frequencies of the seven
platelet antigen systems obtained from 500 Thai blood
Table 1. Sequence of the primers for HPA-1 to 6, Gov, and HGH internal
control
Product Final
Primer Sequence size (bp) Conc.
HPA-1a 5´ TCA CAG CGA GGT GAG GCC A 3´
HPA-1b 5´ TCA CAG CGA GGT GAG GCC G 3´ 90 0.1 µM
HPA-1 common 5´ GGA GGT AGA GAG TCG CCA TAG 3´
HPA-2a 5´ GCC CCC AGG GCT CCT GAC 3´
HPA-2b 5´ GCC CCC AGG GCT CCT GAT 3´ 258 0.1 µM
HPA-2 common 5´ TCA GCA TTG TCC TGC AGC CA 3´
HPA-3a 5´ TGG ACT GGG GGC TGC CCA T 3´ 267
HPA-3b 5´ GGT GGA CTG GGG GCT GCC CAG 3´ 269 0.2 µM
HPA-3 common 5´ TCC ATG TTC ACT TGA AGT GCT 3´
HPA-4a 5´ GCT GGC CAC CCA GAT GCG 3´
HPA-4b 5´ GCT GGC CAC CCA GAT GCA 3´ 120 0.1 µM
HPA-4 common 5´ CAG GGG TTT TCG AGG GCC T 3´
HPA-5a 5´ AGT CTA CCT GTT TAC TAT CAA AG 3´
HPA-5b 5´ AGT CTA CCT GTT TAC TAT CAA AA 3´ 246 0.5 µM
HPA-5 common 5´ CTC TCA TGG AAA ATG GCA GTA 3´
HPA-6a 5´ GAC GAG TGC AGC CCC CG 3´ 238
HPA-6b 5´ GGA CGA GTG CAG CCC CCA 3´ 239 0.2 µM
HPA-6 common 5´ CTA TGT TTC CCA GTG GTT GCA 3´
Gova 5´ TTC AAA TTC TTG GTA AAT CCT GT 3´
Govb 5´ TTC AAA TTC TTG GTA AAT CCT GG 3´ 225 0.4 µM
Gov common 5´ ATG ACC TTA TGA TGA CCT ATT C 3´
HGH control 5´ GCC TTC CCA ACC ATT CCC TTA 3´ HPA-1–4 & 6
0.4 µM
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donors are shown in Table 2. HPA-4a was present in all
samples. HPA-1b, -2b, -5b, and -6b were rare and HPA-
4b was not found. HPA-3a and -3b showed frequencies
of 56.0 percent and 44.0 percent, respectively. Gova
and Govb showed frequencies of 49.1 percent and 50.9
percent, respectively.
To test the reproducibility of the assay, ten DNA
samples were randomly selected and tested for HPA-1
to 6 and Gov typing. The results of the repeated assay
were similar to those of the first round of testing.
Moreover, this PCR-SSP HPA typing method was
validated using 20 HPA reference materials typed by
alternative techniques and in other laboratories. The
results showed a 100 percent concordance between
the two methods.
A comparison of HPA-1 to 6 and Gov gene
frequencies among Asian and Caucasian studies is
presented in Tables 3 and 4.6,12,17–23 The HPA-1 to 6
frequencies in Thai blood donors are more similar to
those in Northeastern Thais and other Asians than to
those of Caucasians. The Gova and Govb frequencies in
our study showed results similar to those in the
previous study23 but were significantly different from
those in the study in UK populations (p < 0.01).24
Discussion
The investigation of HPA gene and genotype
frequencies is important in both population studies
Table 2. The genotype and gene frequencies of HPA-1 to 6 and Gov in
500 Thai blood donors
Genotype
frequencies Gene frequencies
Genotype No. (%) Gene (%)
HPA-1a1a 485 97.0 HPA-1a 98.5
HPA-1a1b 15 3.0 HPA-1b 1.5
HPA-1b1b 0 0.0
HPA-2a2a 452 90.4 HPA-2a 95.2
HPA-2a2b 48 9.6 HPA-2b 4.8
HPA-2b2b 0 0.0
HPA-3a3a 152 30.4 HPA-3a 56.0
HPA-3a3b 256 51.2 HPA-3b 44.0
HPA-3b3b 92 18.4
HPA-4a4a 500 100.0 HPA-4a 100.0
HPA-4a4b 0 0.0 HPA-4b 0.0
HPA-4b4b 0 0.0
HPA-5a5a 468 93.6 HPA-5a 96.8
HPA-5a5b 32 6.4 HPA-5b 3.2
HPA-5b5b 0 0.0
HPA-6a6a 486 97.2 HPA-6a 98.6
HPA-6a6b 14 2.8 HPA-6b 1.4
HPA-6b6b 0 0.0
Gova/Gova 125 25.0 Gova 49.1
Gova/Govb 241 48.2 Govb 50.9
Govb/Govb 134 26.8
Fig. 1. A representative gel showing simultaneous HPA-1 to 6 and Gov
genotyping by PCR-SSP. The 429-bp amplification product of the
HGH control primers is present in all lanes, which shows that
amplification has occurred optimally. The genotype was deduced
from the presence or absence of amplification products specific
for alleles (from left to right: HPA-1b1b, HPA-2a2b, HPA-3a3b,
HPA-4a4a, HPA-5a5a, HPA-6a6a, Gov-a/b). M: 100-bp ladder
marker (Promega, Madison,WI).
1000
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Table 3. Gene frequencies of HPA-1 to 6 in 500 Thai blood donors and different populations
Thai* NET† Taiwan17 Hong Kong18 Korea19 Japan20 Spain21 Wales12 Australia22 Norway23
HPA (N=500) (N=300) (N=300) (N=100) (N=100) (N=331) (N=107) (N=392) (N=1,000) (N=105)
-1a 98.5 97.2 99.7(a) 99.5 99.5 99.8(b) 74.8(c) 82.5(c) 85.8(c) 86.7(c)
-1b 1.5 2.8 0.3(a) 0.5 0.5 0.2(b) 25.2(c) 17.5(c) 14.2(c) 13.3(c)
-2a 95.2 93.8 96.0 97.5 87.0(c) NA‡ 81.8(c) 90.9(c) 92.7(b) 94.3
-2b 4.8 6.2 4.0 2.5 13.0(c) NA 18.2(c) 9.1(c) 7.3(b) 5.7
-3a 56.0 53.3 57.5 52.5 67.0(b) NA 68.2(b) 60.7(a) 61.9(b) 47.1(a)
-3b 44.0 46.7 42.5 47.5 33.0(b) NA 31.8(b) 39.3(a) 38.1(b) 52.9(a)
-4a 100.0 100.0 99.8 100.0 100.0 98.9(b) 100.0 100.0 100.0 100.0
-4b 0.0 0.0 0.2 0.0 0.0 1.1(b) 0.0 0.0 0.0 0.0
-5a 96.8 96.3 98.5(a) 96.5 97.0 NA 86.1(c) 90.3(c) 90.5(c) 92.9(b)
-5b 3.2 3.7 1.5(a) 3.5 3.0 NA 13.9(c) 9.7(c) 9.5(c) 7.1(b)
-6a 98.6 98.5 96.3(b) NA NA 97.3 100.0 100.0(a) NA NA
-6a 1.4 1.5 3.7(b) NA NA 2.7 0.0 0.0(a) NA NA
*Thai blood donors          †Northeastern Thais          ‡No data available          (a) p < 0.05          (b) p < 0.01          (c) p < 0.001
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and clinical transfusion practice, where HPA-typed
platelets may be required for alloimmunized patients.
Providing more data on HPA distribution among
various populations enables the prediction of the risk
of platelet-specific alloimmunization in different ethnic
groups and improves the ability to prepare HPA-
compatible platelet products.2,4
Recent studies reported gene frequencies of the
HPA-1 to 13, Oe, and Gov alleles in Taiwanese,
Indonesian, Filipino, and Thai populations, using the
PCR-RFLP technique.11,25 Although the results were
consistent with other previous findings in Asian
populations, the PCR-RFLP technique has some
disadvantages, such as being time-consuming and
susceptible to being misinterpreted due to incomplete
enzyme digestion of the amplicon.16 In this study we
have established HPA-1 to -6 and Gov genotyping by
PCR-SSP, using a combination of established and
modified sequence-specific primers. This method is
rapid, cost-effective, and suitable in large-scale platelet
antigen genotyping, either for NAIT or in genetic
population studies.4,6,9,10,12,14,17
Furthermore, the distribution of HPA-1 to 6
phenotypes in Thai blood donors living in Bangkok is
consistent with those found in Northeastern
Thailand.6,7 A previous study showed that the most
common HPA antibodies in thrombocytopenic Thai
patients were anti-HPA-5b, -HPA-2b, -HPA-3a, and
unidentified antibodies.Anti-HPA-1a, which is the most
common cause of NAIT and PTP in Caucasians, is not
found in Thai populations due to the high frequency of
HPA-1a (> 97%). Other studies showed that anti-HPA-
1b, -HPA-2a, -HPA-2b, -HPA-3a, -HPA-3b, -HPA-4a, -HPA-4b,
-HPA-5b,-HPA-5a, and -HPA-6a were also found in NAIT,
PTP, and refractoriness to platelet transfusion therapy
in Caucasians and in Japanese populations.24,26–29
The Gov antibodies have been reported for their
clinical importance,especially in NAIT,PTP,and platelet
refractoriness.24,30 Although the incidence of Gov anti-
bodies was lower than that of the HPA-1 system, the
incidence was equal to that of HPA-5 system antibodies
in Caucasians. The genotype frequencies of the Gov
system in this study are comparable to those found in
previous studies in Asian populations.25 Thus, typing
for the Gov antigen system
should be useful in patient
diagnosis. In summary, the
implementation of the HPA
genotyping system using
the PCR-SSP technique in
both donors and patients is
beneficial in platelet transfusion therapy to provide
HPA-matched platelet donors and to increase the
capability for platelet alloantibody investigation.
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